Share
 
Title
Code
Session Type
Channel
Date Time
Co-Chairs:

OA09.01 BCG.HTI2auxo.int priming vaccination enhances the HIV-1 specific T cell immune responses elicited by MVA.HTI
Narcís SAUBI, Vall d'Hebron Institut de Recerca, Spain
Abstract

OA09.02 Anti-Env antibody-independent protection of repeated intrarectal low-dose SIVmac239 challenges in rhesus macaques by vaccination inducing Gag/Vif-specific CD8+ T but not CD4+ T cells
Hiroshi ISHII, National Institute of Infectious Diseases, Japan
Abstract
OA09.03 Impact of HLA-II associated HIV-1 adaptations on vaccine-induced CD4 T-cell immune responses
Jacob FILES, University of Alabama at Birmingham, United States
Abstract

OA09.04 Applying insights from HIV to guide the development of a T cell vaccine for SARS-CoV-2
Anusha NATHAN, Ragon Institute of MGH, MIT, and Harvard, United States
Abstract
OA09.05LB Spontaneous in vivo control of HIV replication is underpinned by the cross-clade antiviral potency of HIV-specific CD8 T cells
Julia MAKINDE, Imperial College London, United Kingdom
Abstract

OA09.06 Live Q&A